Read, Write, Understand the Code of Life
febit's innovative microarray technologies
Are you looking for a DNA/RNA analysis solution that is able to adapt to your changing demands?
Stop searching - start working today: Products and Services based on the Geniom® Technology allow you to obtain efficient and reliable microarray experimentation results from any sequence information very fast.
miRNA Profiling Service with miRBase 12.0
The miRBase is a continuously updated database for miRNA sequences maintained by the Sanger Institute. febit provides services from sample to bioinformatics report based always on the latest miRBase content.
HybSelect - Capturing Genomic Regions
for targeted Next Generation Sequencing (tNGS)
Hybselect is a microarray-based technology enabling targeted Next Generation Sequencing (tNGS) of genomic regions of interest. This technology is now made available to early access researchers interested in tNGS of genomic regions up to 1 Mb.
Beyond miRNAs - ncRNAs Analysis on Flexible Biochips
Abstract: There is more than just miRNAs in the field of non-coding RNAs, which are not yet covered by high-throughput technology at the moment...
-
2. Dezember 2008
febit Appoints Jack Leonard, Ph.D., Vice President of Technology Commercialization
In the newly created position at febit, Dr. Leonard will apply his 15 years of product development experience in the life sciences to help accelerate the commercialization of febit’s Geniom Platform and applications.
-
19. November 2008
febit Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
febit group today announced a strategic investment and technology development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community.
-
20. Oktober 2008
The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febits Geniom RT Analyzer
The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febit´s newly introduced Geniom® RT Analyzer to investigate the association of microRNAs (miRNAs) and cancer.
-
19. November 2008
febit Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
febit group today announced a strategic investment and technology development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community.
-
20. Oktober 2008
The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febits Geniom RT Analyzer
The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febit´s newly introduced Geniom® RT Analyzer to investigate the association of microRNAs (miRNAs) and cancer.
-
1. September 2008
febit first to offer Geniom Biochips based on miRBase 12.0
Today febit announced its latest miRNA Biochip based on the new miRBase version 12.0 which has been released by the Wellcome Trust Sanger Institute early this afternoon.
